-
Information-Publications
-
A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB. 1.16, BQ. 1.1 and sarbecovirusesDetails
-
Kdm4a is an activity downregulated barrier to generate engrams for memory separationDetails
-
Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolismDetails
-
FBXO22 is a potential therapeutic target for recurrent chondrosarcomaDetails
-
Hyperlanins A and B, Two Highly Rearranged Meroterpenoids from Hypericum lancasteriDetails
-
PPTC7 acts as an essential co-factor of the SCFFBXL4 ubiquitin ligase complex to restrict BNIP3/BNIP3L-dependent mitophagyDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands